Literature DB >> 10706577

Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel.

A Demetris1, D Adams, C Bellamy, K Blakolmer, A Clouston, A P Dhillon, J Fung, A Gouw, B Gustafsson, H Haga, D Harrison, J Hart, S Hubscher, R Jaffe, U Khettry, C Lassman, K Lewin, O Martinez, Y Nakazawa, D Neil, O Pappo, M Parizhskaya, P Randhawa, S Rasoul-Rockenschaub, F Reinholt, M Reynes, M Robert, A Tsamandas, I Wanless, R Wiesner, A Wernerson, F Wrba, J Wyatt, H Yamabe.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10706577     DOI: 10.1002/hep.510310337

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  67 in total

1.  Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection.

Authors:  JoonHo Lee; Roberto Romero; Yi Xu; Jung-Sun Kim; Ji Young Park; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Am J Reprod Immunol       Date:  2011-09-27       Impact factor: 3.886

2.  Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.

Authors:  Abraham Shaked; Michele R DesMarais; Heather Kopetskie; Sandy Feng; Jeffrey D Punch; Josh Levitsky; Jorge Reyes; Goran B Klintmalm; Anthony J Demetris; Bryna E Burrell; Allison Priore; Nancy D Bridges; Peter H Sayre
Journal:  Am J Transplant       Date:  2018-12-31       Impact factor: 8.086

3.  Molecular case report: IgVH analysis in acute humoral and cellular liver allograft rejection suggests a selected accumulation of effector B cells and plasma cells.

Authors:  Johannes Moeller; Manfred G Krukemeyer; Lars Morawietz; Max Schmeding; Anja Dankof; Ulf Neumann; Veit Krenn; Claudia Berek
Journal:  Virchows Arch       Date:  2005-02-16       Impact factor: 4.064

Review 4.  Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease.

Authors:  A-J Demetris; John-G Lunz; Susan Specht; Isao Nozaki
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

Review 5.  Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner.

Authors:  Daniel Benten; Katharina Staufer; Martina Sterneck
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-25

Review 6.  Liver transplantation in the UK.

Authors:  S R Bramhall; E Minford; B Gunson; J A Buckels
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

7.  High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant.

Authors:  J G O'Leary; H Kaneku; B M Susskind; L W Jennings; M A Neri; G L Davis; G B Klintmalm; P I Terasaki
Journal:  Am J Transplant       Date:  2011-06-14       Impact factor: 8.086

8.  The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3.

Authors:  David Cassiman; Louis Libbrecht; Nicoletta Sinelli; Valeer Desmet; Carl Denef; Tania Roskams
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  Re-examination of sinusoidal deposition of complement 4d in liver allografts: experience from a single institution.

Authors:  Mohannad Dugum; Medhat Askar; Rish K Pai; Lisa Yerian; Ana Bennett; James McMahon; Hao Xie; Bijan Eghtesad; Ibrahim Hanouneh; Xiuli Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts.

Authors:  Aya Miyagawa-Hayashino; Tatsuaki Tsuruyama; Hiroto Egawa; Hironori Haga; Hiromi Sakashita; Tomoko Okuno; Shinya Toyokuni; Keiji Tamaki; Hirohiko Yamabe; Toshiaki Manabe; Shinji Uemoto
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.